title: Biotechnology patent disputes. Amgen plays for time.
authors.forename: D
authors.initials: D
authors.lastname: Gershon
mesh_terms: D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004921:Erythropoietin; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011994:Recombinant Proteins; D014481:United States
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin